Nova Patents
BG98902A

Imidazole derivatives and their usage as cytokine inhibitors

Abstract

Imidazole derivatives are used in the pharmaceutical industry. They are useful in treating various viral infections. The derivatives have the structure presented in the description.

Term

Term ended

Expired 12 July 2014, 12.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

57 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
81955192United States of AmericaA
81955192United States of AmericaA
86724992United States of AmericaA
86724992United States of AmericaA
9300674United States of AmericaW
9300674United States of AmericaW
819551–––
867249–––
PCTUS9300674–––
US19920819551–––
US19920867249–––
WO1993US00674–––

Members57

Family members, oldest first
DocumentOfficeKind
IL104369D0IsraelD0
CA2127876A1CanadaA1
CA2314425A1CanadaA1
CA2351694A1CanadaA1
CA2368862A1CanadaA1
WO9314081A1World Intellectual Property Organization (WIPO)A1
AU3592393AAustraliaA
ZA93213BSouth AfricaB
CN1083473AChinaA
NO942618D0NorwayD0
FR2700331A3FranceA3
ES2053401A1SpainA1
MX9300141AMexicoA
NO942618LNorwayL
FI943319AFinlandA
FI943319A7FinlandA7
FI943319LFinlandL
HU9402092D0HungaryD0
EP0623126A1European Patent Office (EPO)A1
PT101273APortugalA
FR2700331B3FranceB3
CZ168894A3CzechiaA3
WO9503297A1World Intellectual Property Organization (WIPO)A1
AU7629594AAustraliaA
ES2053401B1SpainB1
SK83594A3SlovakiaA3
ZA945363BSouth AfricaB
JPH07503017AJapanA
BG98902AThis recordBulgariaA
HUT69714AHungaryA
OA09963AAfrican Intellectual Property Organization (OAPI)A
RU94035756ARussian FederationA
NZ249301ANew ZealandA
AU671271B2AustraliaB2
BR9305809ABrazilA
US5656644AUnited States of AmericaA
US5686455AUnited States of AmericaA
US5916891AUnited States of AmericaA
EP0943616A1European Patent Office (EPO)A1
US6268370B1United States of AmericaB1
JP2002097189AJapanA
JP3298641B2JapanB2
US2003064997A1United States of AmericaA1
CA2127876CCanadaC
US6645989B2United States of AmericaB2
EP0623126B1European Patent Office (EPO)B1
AT275556TAustriaT
ATE275556T1AustriaT1
DE69333616D1GermanyD1
ES2227517T3SpainT3
EP0943616B1European Patent Office (EPO)B1
AT294795TAustriaT
ATE294795T1AustriaT1
DE69333805D1GermanyD1
DE69333616T2GermanyT2
ES2242351T3SpainT3
DE69333805T2GermanyT2